DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dbcv5l/the) has announced the addition of the "The Pharmaceutical Market: Central America" report to their offering.
The political instability and underdeveloped economies in many Central American countries make the region less attractive to multinationals, compared with most neighbouring countries. However, the heavy reliance on imported medicine in the region provides revenue-generating opportunities for generic drug makers from neighbouring Latin American countries and India. We highlight that Costa Rica and Panama can be the premier countries in the region for foreign drugmakers to expand their presence .
In the report Q1 Pharmaceutical Risk/Reward Ratings (RRRs), based on our analysis and assessment of the market's appeal to pharmaceutical companies, the Americas region continues to rank second lowest globally with a score of 49.4 out of 100; behind Western Europe (66), Asia Pacific (53) and Central and Eastern Europe (51), but ahead of the Middle East and Africa (44). Of the seven Central American countries surveyed, Costa Rica's RRR score has changed in Q1, up from 39.2 in Q4 to 40.7 this quarter, reflecting the country's increasing attractiveness to multinational drugmakers. Meanwhile Honduras' RRR score has reduced from 31.5 in Q412 to 28.5 in Q1.
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Examines the competitive positioning and short- to medium-term business strategies of key industry players. Strategy is examined within the context of the industry forecasts, our macroeconomic views and our understanding of the wider competitive landscape to generate Company SWOT analyses. The latest financial and operating statistics and key company developments are also incorporated within the company profiles, enabling a full evaluation of recent company performance and future growth prospects.
- Ancalmo Internacional
- Donovan Werke
For more information visit http://www.researchandmarkets.com/research/dbcv5l/the